Tesamorelin 30mg
GHH Pharma Grade
FDA-Approved Visceral Fat Eliminator

Tesamorelin 30mg

GHRH analogue — visceral fat reduction & body recomposition

AED 2,779.00
Physician Required

Tesamorelin is an FDA-approved synthetic GHRH analogue (TransCon hGH) specifically studied and approved for visceral adiposity — excess fat accumulation around internal organs. It is the only peptide with FDA approval specifically for lipodystrophy and abdominal fat reduction. Clinical trials show 15–20% reduction in visceral fat, improved metabolic markers, and cardiovascular risk reduction.

💉
Injectable / Oral
Administration
⏱️
2–4 weeks
First Results
🔄
26-week primary course (based on clinical trial design). Reassess with imaging and labs.
Cycle Length
🎯

Clinical Uses

What conditions & goals this peptide addresses

Visceral (abdominal) fat reduction
HIV-associated lipodystrophy (FDA-approved)
Metabolic syndrome
Cardiovascular risk reduction
Non-alcoholic fatty liver disease
Growth hormone deficiency
Body composition optimisation
✨

Key Benefits

The measurable outcomes you can expect

FDA-approved specifically for abdominal fat
15–20% visceral fat reduction in trials
Improves triglycerides and HDL/LDL ratio
Reduces liver fat (NAFLD)
Preserves lean muscle mass during fat loss
Improves cognitive function (studied in elderly)
Cardiovascular risk marker improvement
🔬

How It Works — Mechanism of Action

The precise biology behind this peptide's effects

Tesamorelin binds to GHRH receptors in the pituitary, stimulating GH release. Unlike other GHRH analogues, its clinical development specifically targeted visceral fat — studies show it selectively mobilises omental and mesenteric fat depots without significant effect on subcutaneous fat. Elevated GH drives lipolysis in visceral adipocytes via hormone-sensitive lipase activation.

Administration Guide

Subcutaneous injection into the abdomen. Reconstitute with provided sterile water (not bacteriostatic). Inject at same time daily. Rotate injection sites within the abdomen.

💊

Dosage Protocol

GHH physician-guided dosing guidelines

FDA-approved dose: 2 mg subcutaneous daily. Clinical trials all used 2 mg/day. Some physicians use 1 mg/day for maintenance. Monitor IGF-1 at 3-month intervals.

🔄
Cycle Length
26-week primary course (based on clinical trial design). Reassess with imaging and labs.
🧊
Storage
Lyophilized: Refrigerate 2–8°C. Reconstituted: Use immediately or within 24 hours. Do not freeze.
⏳

When to Expect Results

A realistic timeline from first dose to full effect

Measurable visceral fat reduction: 4–8 weeks. Significant (15–20%) visceral fat loss: 12–26 weeks. Metabolic marker improvement: 8–12 weeks.

Day 1–7
Week 2–4
Week 4–8
Week 8–16
⚠️

Side Effects

What to watch for and how common they are

Well tolerated. Common: injection site reactions. GH-related: water retention, joint discomfort, glucose elevation (monitor). Rare: carpal tunnel, peripheral neuropathy.

🚫

Contraindications

Who should not use this peptide

Active cancer. Pituitary tumor or prior pituitary irradiation. Pregnancy. Diabetic retinopathy. Active acromegaly.

⚡

Best Stacked With

Peptide synergies recommended by GHH physicians

AOD-9604 for enhanced fat-burning synergy Ipamorelin for dual-mechanism GH optimisation NAD+ for metabolic enhancement

Compare this peptide side-by-side

See how it stacks up against other protocols

🩺

Ready to Start Your Tesamorelin Protocol?

All peptide protocols require a physician consultation and blood work. Our licensed UAE physicians will craft a personalised plan for you.

The Science of Peptides

Understanding Your Body's Language

Peptides are not exotic foreign chemicals — they are the precise molecular signals your body has evolved to use for billions of years. Here's what you need to know.

🔭
"Peptides don't change who you are — they restore who you were designed to be."

— German Health Hub Clinical Philosophy

All peptides require UAE licensed physician review and mandatory blood work before dispensing. Information presented is for educational purposes only and does not constitute medical advice. Individual results may vary. Peptides are prescribed and dispensed under strict medical supervision by German Health Hub's licensed clinical team.